Biotech

Categories
LTP Special Column (237) Fintech (23) Blockchain / Digital Asset (5) ESG (24) Mergers & Acquisitions / Cross-border Investment (11) Capital Market / Securities (249) General Corporate Affairs (154) Infrastructure Projects / Construction Laws (106) Trade Secret (18) Trademark (45) Patent (31) Copyright (84) Competition Law (80) Biotech (32) Energy (13) Media / Entertainment (55) Employment Law (118) Personal Data Protection (38) Arbitration / Litigation (329) Tax (56) Environmental Protection Law (8) PRC Investment and Legal Compliance (34) Other Areas (231)

March 2025

Series Articles of the Regenerative Medicine Dual Legislation (4) – Draft Announcement of Certain Subsidiary Regulations Under the Regenerative Medicinal Products Act (Taiwan)

Teresa Huang

Oli Wong

David Hung

February 2025

Amendment to the Enforcement Rules of the National Health Insurance Act: Abolishment of Suspension and Resumption Mechanism in National Health Insurance Coverage (Taiwan)

Teresa Huang

Elesha Wang

February 2025

Dispute over Advance Payment of Medical Fees: Taiwan Constitutional Court Deems It Constitutional

Oli Wong

February 2025

Amendment to the Enforcement Rules of the National Health Insurance Act: Abolishment of Suspension and Resumption Mechanism in National Health Insurance (Taiwan)

December 2024

Review of Supporting Policies for the Biomedical Industry in Shanghai (Mainland China)

December 2024

Review of Supporting Policies for the Biomedical Industry in Shanghai (Mainland China)

Yanting Pei

Teresa Huang

September 2024

Taiwan’s Ministry of Health and Welfare Amends the Enforcement Rules of the Medical Care Act to Regulate Overcharged Expenses and Restrict Disclosure of Medical Expert Testimony

September 2024

Series Articles of the Regenerative Medicine Dual Legislation (3) – The Impact of the Regenerative Medicine Dual Acts on the Therapy and Drug Development of Rare Diseases

Chung Teh Lee

Teresa Huang

Oli Wong

Vincent Kuo

July 2024

The National Healthcare Security Administration Has Issued a Notice on Further Promoting the Experience of Medical Reform in Sanming City to Continuously Promote the Innovative Development of Medical Insurance (Mainland China)

July 2024

Series Articles of the Regenerative Medicine Dual Legislation (2) – Analysis of the Conditional Approval System for Regenerative Medicine Product

Teresa Huang

Hannah Kuo

David Hung
< 1 2 3 4 >